fgfr2b: a novel biomarker for patients with gastroesophageal cancer
Published 1 year ago • 71 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
2:17
claudin 18.2 and fgfr2b as novel targets in gastric cancer
-
2:09
collagen fiber immune architecture as novel biomarker for gynecological cancers treated with io
-
1:07
claudin 18.2: a biomarker for gastric cancer
-
0:29
biomarker testing in gastroesophageal cancer
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
5:26
fight update: 1l bemarituzumab in fgfr2b gastric cancer
-
27:04
webinar: first-in human-studies of fgfr inhibitor kin-3248 and raf inhibitor kin-2787
-
4:59
a novel biomarker for paediatic tumours
-
4:16
the role of the trop2 biomarker in cancer
-
25:47
2017 ccf annual conference #10 - day 2 - fgfr pathway
-
1:35
assessing the prevalence of cldn18.2 in gastric/gastroesophageal cancers
-
1:20
(pro)renin receptor: an emerging biomarker and target for fighting cancer
-
17:23
2018 cholangiocarcinoma foundation annual conference #11 - day 2 - fgfr inhibition
-
0:59
what are fgfr genes?
-
0:58
lb1908: a novel car-t cell therapy targeting claudin 18.2 in gi malignancies
-
1:51
fgfr inhibitors
-
6:47
fgfr screening - the pathologist perspective
-
30:12
2018 cholangiocarcinoma foundation annual conference #10 - day 2 - fgfr signaling